{"id":4386,"date":"2026-02-13T09:15:13","date_gmt":"2026-02-13T09:15:13","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/4386\/"},"modified":"2026-02-13T09:15:13","modified_gmt":"2026-02-13T09:15:13","slug":"roche-promises-1b-to-china-biotech-for-preclinical-copd-bispecific","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/4386\/","title":{"rendered":"Roche promises $1B to China biotech for preclinical COPD bispecific"},"content":{"rendered":"<p>Roche is team\u00ading up with Jiang\u00adsu, Chi\u00adna-based Qyuns Ther\u00ada\u00adpeu\u00adtics for a bis\u00adpe\u00adcif\u00adic an\u00adti\u00adbody that could po\u00adten\u00adtial\u00adly treat asth\u00adma, COPD and oth\u00ader res\u00adpi\u00adra\u00adto\u00adry dis\u00adeases.<\/p>\n<p> To start \u2026<\/p>\n<p>    <img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/endpoints.news\/wp-content\/themes\/endpoints-rakia\/assets\/svg\/epn_logo.svg\" alt=\"Endpoints News\"\/><br \/>\n    Sign up to read this article for free.<\/p>\n<p>Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.<\/p>\n","protected":false},"excerpt":{"rendered":"Roche is team\u00ading up with Jiang\u00adsu, Chi\u00adna-based Qyuns Ther\u00ada\u00adpeu\u00adtics for a bis\u00adpe\u00adcif\u00adic an\u00adti\u00adbody that could po\u00adten\u00adtial\u00adly treat asth\u00adma,&hellip;\n","protected":false},"author":2,"featured_media":4387,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[3780,2993,351,3773,3774,3772,2536,3779,3776,3775,3777,134,3778],"class_list":["post-4386","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-astegolimab","tag-bispecific-antibody","tag-china","tag-china-biotech-deals","tag-copd-treatment","tag-deals","tag-pharma","tag-pharma-partnerships","tag-qx031n","tag-qyuns-therapeutics","tag-respiratory-diseases","tag-roche","tag-tslp-il-33-antibody"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/4386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=4386"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/4386\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/4387"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=4386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=4386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=4386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}